Skip to main content

Table 7 Univariate and multivariate analyses for survival time from recurrence detection until death due to breast cancer

From: Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence

  Survival time
  Univariate analysis p Value Multivariate analysis p Value
ALDH1, 1 %/>1 % 1.552 (1.057–2.218) 0.025 1.451 (0.985–2.085) 0.059
Age, ≤50/>50 years 1.160 (0.856–1.581) 0.338 Not selected  
Bilateral breast cancer absent/present 0.813 (0.438–1.376) 0.438 Not selected  
Tumor size, ≤20/>20 mm 1.062 (0.764–1.503) 0.721 Not selected  
Nodal status negative/positive 1.500 (1.109–2.032) 0.008 1.387 (1.020–1.890) 0.036
Progesterone receptor staining, <20 %/≥20 % 0.789 (0.582–1.072) 0.130 0.778 (0.572–1.060) 0.111
Ki-67 staining, <20 %/≥20 % 1.270 (0.888–1.781) 0.184 1.208 (0.839–1.706) 0.301
Tumor grade 1 or 2/3 1.519 (1.080–2.105) 0.016 1.438 (1.019–1.999) 0.038
  1. ALDH1 aldehyde dehydrogenase 1